(Press-News.org) PHILADELPHIA — Using a highly sensitive technology called NanoString, researchers have identified seven targets that could potentially be used to develop new immunotherapies for patients with metastatic melanoma, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
"We identified seven potential candidate genes that deserve further consideration as targets for melanoma immunotherapy," said Richard Morgan, Ph.D., staff scientist at the Tumor Immunology Section of the Center for Cancer Research, National Cancer Institute (NCI), in Bethesda, Md. "We used NanoString technology because it is very robust, yielding quantitative and extremely reproducible results and, in addition, an antigen expression profile can be constructed for a patient from a very small amount of tumor sample, which makes NanoString a better clinical tool."
NanoString technology allows for the simultaneous measurement of multiple genes that are expressed in higher amounts in tumor cells than in normal cells. Researchers isolate genetic material called RNA from tumor samples, use this technology to measure the amount of RNAs present in tumors, and compare them with those present in normal tissues. Unlike many other technologies that can be used for this purpose, NanoString can detect and measure the expression levels of the genes in a single step, avoiding errors.
"Our laboratory has developed a battery of different antigen receptors to target a wide range of antigens, and we can engineer human immune cells to recognize the targets in patients' tumors and kill those cells," said Morgan. "The NCI surgery branch is conducting several clinical trials using this technology to treat a variety of cancers."
In these clinical trials, the NCI researchers are treating patients with adoptive immunotherapy, a type of cancer treatment that involves "teaching" the immune cells of a patient to locate specific targets on tumor cells and kill those cells. Identification of the right targets present in a patient's tumor is, therefore, essential for immunotherapy to be successful.
Morgan and colleagues took metastatic melanoma samples from 59 patients, five established melanoma cell lines, and 31 normal tissue samples to profile the excessively expressed genes using NanoString. The researchers identified 67 genes that can be recognized by immune cells as targets on melanoma cells. They subsequently short-listed seven of these genes as ideal candidates because these genes fit the criteria: they were excessively expressed in melanoma tumors and were absent or at low levels in normal tissues, thus targeting them should cause no or minimal toxicity to nontarget organs.
Of these seven genes, five of them, CSAG2, IL13RA2, MAGEA3, MAGEC2, and PRAME, belong to a family called the cancer-testis genes, and the remaining two, CSPG4 and SOX10, are melanoma-related genes. Further investigation is needed before immune cells engineered to target these markers can be used in patients, according to Morgan.
"This is a good example of how newer technologies like NanoString arm cancer researchers and clinicians with the best gear to make tremendous advancements in cancer research and treatment," said Morgan. His team is currently using this technology to identify immunotherapy targets for pancreatic cancer.
###
To interview Richard Morgan, please contact the NCI Press Office at ncipressofficers@mail.nih.gov or 301-496-6641. For other inquiries, contact Jeremy Moore at jeremy.moore@aacr.org or 215-446-7109.
Follow the AACR on Twitter: @AACR
Follow the AACR on Facebook: http://www.facebook.com/aacr.org
About the American Association for Cancer Research
Founded in 1907, the American Association for Cancer Research (AACR) is the world's oldest and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 34,000 laboratory, translational, and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in more than 90 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis, and treatment of cancer by annually convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with more than 18,000 attendees. In addition, the AACR publishes eight peer-reviewed scientific journals and a magazine for cancer survivors, patients, and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the scientific partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration, and scientific oversight of team science and individual grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and policymakers about the value of cancer research and related biomedical science in saving lives from cancer. For more information about the AACR, visit http://www.AACR.org.
NCI scientists identify targets for melanoma immunotherapy
2013-09-11
ELSE PRESS RELEASES FROM THIS DATE:
Heart disease patients with positive attitudes likely to exercise, live longer
2013-09-11
Heart disease patients with positive attitudes are more likely to exercise and live longer, according to new research in the American Heart Association journal Circulation: Cardiovascular Quality and Outcomes.
Researchers used a questionnaire to assess the moods of 600 ischemic heart disease patients in a Denmark hospital. Five years later, researchers found:
The most positive patients exercised more and had a 42 percent less chance of dying for any reason during the follow-up period; deaths were less than 10 percent.
Among patients with less positive attitudes, 50 ...
Cost, fear, lack of information may limit CPR usage for urban minorities
2013-09-11
Cost, fear and a lack of information are barriers for minorities in urban communities to learn and perform CPR, according to new research in the American Heart Association journal Circulation: Cardiovascular Quality and Outcomes.
In a small study, researchers interviewed 42 residents in Columbus, Ohio. The majority of participants were age 30 or older, African-American and female. Participants attended six focus groups and were asked about their knowledge of and training in CPR. Almost half of the participants lived in economically struggling, high-crime neighborhoods, ...
Obstructive lung disease linked with decline in memory and information processing
2013-09-11
Barcelona, Spain: Obstructive lung disease (OLD) has been linked with a decline in cognitive functioning, including memory and information processing.
A new study, which will be presented today (11 September 2013) at the European Respiratory Society (ERS) Annual Congress, suggests that impaired cognitive functioning could be an important factor in OLD.
Previous research has found that people with OLD, including COPD, often experience global cognitive impairments, but this new study – using the UK Biobank Resource – focused on which domain-specific cognitive functions ...
Individual financial incentives result in greater blood pressure control
2013-09-11
In an examination of the effect of financial incentives on hypertension care at 12 outpatient clinics, physician-level (individual) financial incentives, but not practice-level or combined incentives, resulted in greater blood pressure control or appropriate response to uncontrolled blood pressure, according to a study in the September 11 issue of JAMA. None of the incentives resulted in greater use of guideline-recommended medications compared with controls.
"As part of the Affordable Care Act, the U.S. government has introduced pay for performance to all hospitals paid ...
Incentive program for small practices with EHRs results in improvement in CV outcomes
2013-09-11
A pay-for-performance program in electronic-health-records-(EHR)-enabled small practices led to modest improvements in cardiovascular care processes and outcomes, according to a study in the September 11 issue of JAMA.
"Most evaluations of pay-for-performance (P4P) incentives have focused on large-group practices," according to background information in the article. Small practices, where the majority of patients still receive care nationally, historically have provided lower-quality care—especially solo practices—and may have greater obstacles to improving care because ...
Use of EHRs for patients with diabetes linked with reduction in ED visits, hospitalizations
2013-09-11
Among patients with diabetes, use of an outpatient electronic health record (EHR) in an integrated healthcare delivery system was associated with modest reductions in emergency department visits and hospitalizations, but was not associated with a change in office visit rates, according to a study in the September 11 issue of JAMA.
The Health Information Technology for Economic and Clinical Health (HITECH) Act authorizes up to $27 billion during 10 years to promote meaningful use of EHRs, with penalties for lack of EHR use beginning in 2015. With these substantial incentives, ...
Combination therapy for severe alcoholic hepatitis does not result in improved survival
2013-09-11
Four weeks of treatment with a combination of the drug pentoxifylline and the corticosteroid prednisolone did not improve 6-month survival compared with prednisolone alone in 270 patients with severe alcoholic hepatitis, according to a study in the September 11 issue of JAMA.
Treatment of severe forms of alcoholic hepatitis is extremely challenging because of the poor outcome. European and U.S. guidelines recommend the use of prednisolone or pentoxifylline in patients with severe alcoholic hepatitis. Nevertheless, a substantial proportion of patients die after 6 months ...
Use of EHRs associated with higher rate of detection of growth disorders in children
2013-09-11
"Monitoring of linear growth is a well-established part of pediatric health care in the developed world. Although monitoring aims to support early diagnosis and timely treatment of disorders affecting growth, such disorders are often diagnosed late," write Ulla Sankilampi, M.D., Ph.D., of Kuopio University Hospital, Kuopio, Finland, and colleagues.
As reported in a Research Letter, the authors compared the effectiveness of a novel computerized and automated growth monitoring (AGM) strategy integrated into an electronic health record (EHR) system in the primary care setting ...
Improved adherence to preventive antiretroviral therapy may reduce transmission of HIV
2013-09-11
A recently completed substudy of a larger clinical trial found that pre-exposure prophylaxis -- a new strategy to prevent HIV infection by prescribing a daily antiretroviral drug to at-risk individuals -- can be a powerful tool when participants take their medications. The trial of this strategy, also called PrEP, enrolled uninfected individuals in East Africa with an HIV-positive sexual partner and found that a combination of objective monitoring of how often participants took their daily medications and intensive counseling of those with lower rates of adherence prevented ...
Pay for performance encouraged physicians to follow blood pressure guidelines
2013-09-11
HOUSTON (Sept. 11, 2013) – When health care pundits began to suggest that pay-for-performance would solve some of health care's woes, Dr. Laura Petersen, professor of medicine at Baylor College of Medicine and director of the Houston VA Health Services Research and Development Center of Excellence, had questions.
How do we know that it will solve those problems? she asked. How do we know whether or not it will create new problems? And how will we structure these payments? As a recognized expert in the area of health care services and quality, she set out to find the ...